(Q24185870)

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-em

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Comparative use of urinary and recombinant human chorionic gonadotropins in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

The combination of urinary and recombinant HCG improves outcome in patients with decreased oocyte/follicle ratio in previous cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Use of recombinant human chorionic gonadotropin in ovulation induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Age-matched comparison of recombinant and urinary HCG for final follicular maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Maturation in vitro of immature human oocytes for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Ovarian stimulation: today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Glycoprotein Hormones: Structure and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

The empty follicle syndrome: a pharmaceutical industry syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.

21 January 2018

1 reference

12 December 2020

The efficacy of recombinant versus urinary HCG in ART outcome.

1 reference

12 December 2020

Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome

1 reference

12 December 2020

Comparison of urinary and recombinant human chorionic gonadotropin during ovulation induction in intrauterine insemination cycles: a prospective randomized clinical trial

1 reference

12 December 2020

Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles

1 reference

12 December 2020

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group

1 reference

12 December 2020

Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction

1 reference

12 December 2020

[Therapeutic induction of ovulation: towards the replacement of hCG with LH]

1 reference

12 December 2020

[Clinical use of recombinant gonadotropins (FSH, LH, hCG)]

1 reference

12 December 2020

Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles

1 reference

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD003719.PUB4

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD003719.PUB4

1 reference

Consolidated OpenCitations Corpus – April 2017

2555813

2555813

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference